Rescuing Light-Sensitive Cells in GUCY2D and GUCA1A Retinopathies
Official title: Mechanisms to Rescue Photoreceptors in GUCY2D and GUCA1A Retinopathies
Funded at Drexel University · NIH-11419626 · Data updated 2026-11-12
Aimed at protecting and saving vision for people with specific genetic forms of blindness by calming overactive signals that damage photoreceptor cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $358,986 |
| NIH project number | 5R01EY034861-05 |
| Project ID | NIH-11419626 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with GUCY2D- or GUCA1A-related retinopathies or similar inherited retinal conditions who may benefit from future therapeutic approaches.
✕Less likely to help
Patients without these specific genetic forms or without retinal degeneration in the studied pathway may not experience direct benefit.
What this research studies
This project focuses on genetic forms of retinal degeneration caused by GUCY2D and GUCA1A mutations. It uses mouse models to understand how overactive signaling leads to cell death and tests strategies to calm this pathway. The work seeks to translate findings toward therapies that could preserve or restore sight for patients with these inherited retinal diseases.
Why it matters
Potential benefit: If successful, the research could lead to therapies that slow or prevent photoreceptor death, helping patients maintain vision longer.
How similar studies have gone: Previous work has established the disease mechanism and animal models; this proposal advances toward therapeutic strategies, which is promising but still experimental.
Where this research is happening
-
Drexel University
Philadelphia, United States Active
Researchers
- Principal investigator: Dizhoor, Alexander M — Drexel University
- Study coordinator: Dizhoor, Alexander M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.